Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.

Binder EB, Owens MJ, Liu W, Deveau TC, Rush AJ, Trivedi MH, Fava M, Bradley B, Ressler KJ, Nemeroff CB.

Arch Gen Psychiatry. 2010 Apr;67(4):369-79. doi: 10.1001/archgenpsychiatry.2010.18.

PMID:
20368512
2.

Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.

Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW.

Arch Gen Psychiatry. 2007 Jun;64(6):689-97.

PMID:
17548750
3.

Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.

Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L.

J Affect Disord. 2007 Dec;104(1-3):83-90. Epub 2007 Apr 30.

PMID:
17467808
4.
5.

Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.

Garriock HA, Tanowitz M, Kraft JB, Dang VC, Peters EJ, Jenkins GD, Reinalda MS, McGrath PJ, von Zastrow M, Slager SL, Hamilton SP.

Am J Psychiatry. 2010 May;167(5):565-73. doi: 10.1176/appi.ajp.2009.08081167. Epub 2010 Mar 1.

6.

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

Liu Z, Zhu F, Wang G, Xiao Z, Tang J, Liu W, Wang H, Liu H, Wang X, Wu Y, Cao Z, Li W.

Neurosci Lett. 2007 Mar 6;414(2):155-8. Epub 2006 Dec 15.

PMID:
17258395
7.

Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system.

Ribbe K, Ackermann V, Schwitulla J, Begemann M, Papiol S, Grube S, Sperling S, Friedrichs H, Jahn O, Sillaber I, Gefeller O, Krampe H, Ehrenreich H.

Arch Gen Psychiatry. 2011 Dec;68(12):1247-56. doi: 10.1001/archgenpsychiatry.2011.100. Epub 2011 Aug 1.

PMID:
21810631
8.

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.

Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, Stock EG.

Depress Anxiety. 2010 May;27(5):417-25. doi: 10.1002/da.20695.

PMID:
20455246
9.

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.

Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH.

Depress Anxiety. 2009;26(7):612-21. doi: 10.1002/da.20568.

PMID:
19382183
10.

Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.

Mitjans M, Gastó C, Catalán R, Fañanás L, Arias B.

J Psychopharmacol. 2012 Oct;26(10):1391-8. doi: 10.1177/0269881112454229. Epub 2012 Jul 23.

PMID:
22826533
11.

Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors.

Arias B, Serretti A, Mandelli L, Gastó C, Catalán R, Ronchi DD, Fañanás L.

Pharmacogenet Genomics. 2009 Feb;19(2):121-8. doi: 10.1097/FPC.0b013e32831ebb4b.

PMID:
19065121
12.

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS.

Brain Res. 2006 Nov 6;1118(1):176-82. Epub 2006 Sep 18.

PMID:
16979146
13.

Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.

Van Den Eede F, Venken T, Del-Favero J, Norrback KF, Souery D, Nilsson LG, Van den Bossche B, Hulstijn W, Sabbe BG, Cosyns P, Mendlewicz J, Adolfsson R, Van Broeckhoven C, Claes SJ.

Psychiatry Res. 2007 Sep 30;153(1):17-25. Epub 2007 Jun 28.

PMID:
17599466
14.

Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression.

Liu Z, Zhu F, Wang G, Xiao Z, Wang H, Tang J, Wang X, Qiu D, Liu W, Cao Z, Li W.

Neurosci Lett. 2006 Sep 1;404(3):358-62. Epub 2006 Jul 3.

PMID:
16815632
15.

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH.

Arch Gen Psychiatry. 2007 Jul;64(7):783-92.

PMID:
17606812
16.

Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.

Tsai SJ, Hong CJ, Liou YJ, Chen TJ, Chen ML, Hou SJ, Yen FC, Yu YW.

Psychiatry Res. 2009 Sep 30;169(2):113-7. doi: 10.1016/j.psychres.2008.06.028. Epub 2009 Aug 22.

PMID:
19700204
17.

Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

Lesser IM, Castro DB, Gaynes BN, Gonzalez J, Rush AJ, Alpert JE, Trivedi M, Luther JF, Wisniewski SR.

Med Care. 2007 Nov;45(11):1043-51.

PMID:
18049344
18.

Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.

Okumura T, Kishi T, Okochi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Tsunoka T, Inada T, Ozaki N, Iwata N.

Neuropsychobiology. 2010;61(2):57-63. doi: 10.1159/000265130. Epub 2009 Dec 12.

PMID:
20016223
19.

SLC6A4 variation and citalopram response.

Mrazek DA, Rush AJ, Biernacka JM, O'Kane DJ, Cunningham JM, Wieben ED, Schaid DJ, Drews MS, Courson VL, Snyder KA, Black JL 3rd, Weinshilboum RM.

Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):341-51. doi: 10.1002/ajmg.b.30816.

20.

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.

Arias B, Serretti A, Lorenzi C, Gastó C, Catalán R, Fañanás L.

J Affect Disord. 2006 Feb;90(2-3):251-6. Epub 2005 Dec 13.

PMID:
16356553

Supplemental Content

Support Center